United Therapeutics (UTHR)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Pulmonarysrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-10-16. ClinicalTrials.gov
Dilution Risk
LOW DILUTION RISKDilution score: 11/100 (LOW), cash runway not available
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 9.24% of float, squeeze risk: MODERATE
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- Is United Therapeutics (UTHR) Undervalued After Its Legal Settlement?
- United Therapeutics (UTHR) Stock May Be Undervalued Following The Litigation Settlement
- United Therapeutics (UTHR) Settles Litigation And Resets Pulmonary Hypertension Competition
- What to Know as Liquidia, United Therapeutics Settlement Sends LQDA Stock Soaring
- Sector Update: Healthcare Stocks Gain Late Afternoon
- Liquidia shares surge 25% as settlement ends United Therapeutics litigation
- United Therapeutics and Liquidia Just Ended Their Patent War. Liquidia Stock Popped 42%
- SGIOY or UTHR: Which Is the Better Value Stock Right Now?
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- Participant experiences of stopping ART as part of a clinical trial; findings from a qualitative study within the RIO trial in the United Kingdom. — HIV Res Clin Pract 2026 Dec 31 PMID 42826224
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for United Therapeutics.
Full UTHR Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.